Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Cancer Res. 2010 Jun 22;70(13):5628–5638. doi: 10.1158/0008-5472.CAN-10-0595

Figure 4.

Figure 4

RAGEv1 inhibits MAPK signaling (A-D) Cells (mock and RAGEv1) were stimulated with RAGE-ligand for the indicated times, lysed and subjected to western blot with antibodies for phospho-status and total of SAPK/JNK, MEK 1/2, p38 and AKT for the indicated times. Activity levels are expressed as a ratio of phospho/total levels. Data are means ± s.e.m from three independent experiments. Significant differences (P ≤ 0.05) between groups are indicated by an asterisk.